Increased circulating leptin in alcoholic cirrhosis: Relation to release and disposal

Hepatology

Volumn 29, Issue 6, 1999, Pages 1818-1824

  Henriksen, J H ^a   Holst, J J ^a   Moller, S ^a   Brinch, K ^a   Bendtsen, F ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; LEPTIN;

ADULT; AGED; ALCOHOL LIVER CIRRHOSIS; ARTICLE; BODY SIZE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOOD INTAKE; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HORMONE RELEASE; HORMONE SYNTHESIS; HUMAN; KIDNEY CLEARANCE; MALE; PRIORITY JOURNAL; SPLANCHNIC BLOOD FLOW;

EID: 0033023477     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510290601     Document Type: Article

References (44)

1. 1 Friedman JM. Leptin, leptin receptors and the control of body weight. Eur J Med Res 1997 ; 2: 7–13.
2. 2 Frühbeck G, Jebb SA, Prentice AM. Leptin: physiology and pathophysiology. Clin Physiol 1998 ; 18: 399–419. MEDLINE
3. 3 Tartaglia LA, Dembski M, Weng X, Deng N, Culpepper J, Devos R, Richards GJ, et al. Identification and expression cloning of a leptin receptor OB‐R. Cell 1995 ; 83: 1263–1271. MEDLINE
4. 4 Caro JF, Sinha MK, Kolaczynski JW, Zhang PL, Considine RV. Leptin: the tale of an obesity gene. Diabetes 1996 ; 45: 1455–1462. MEDLINE
5. 5 Vaisse C, Halaas JL, Horvath CM, Darnell JE, Stoffel M, Friedman JM. Leptin activation of stat 3 in the hypothalamus of wild‐type and ob/ob mice but not db/db mice. Nat Genet 1996 ; 14: 95–97. MEDLINE
6. 6 Kennedy A, Gettys TW, Watson P, Wallace P, Ganaway E, Pan Q, Garvey WT. The metabolic significance of leptin in humans: gender‐based differences in relationship to adiposity, insulin sensitivity, and energy expenditure. J Clin Endocrinol Metab 1997 ; 82: 1293–1300. MEDLINE
7. 7 Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, et al. Serum immunoreactive‐leptin concentrations in normal weight and obese humans. N Engl J Med 1996 ; 334: 292–295. MEDLINE
8. 8 Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 1995 ; 269: 546–549. MEDLINE
9. 9 Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, et al. Weight‐reducing effects of the plasma protein encoded by the obese gene. Science 1995 ; 269: 543–546. MEDLINE
10. 10 Saladin R, De Vos P, Guerre‐Millo M, Leturque A, Girard J, Staels B, Auwerx J. Transient increase in obese gene expression after food intake or insulin administration. Nature 1995 ; 377: 527–529. MEDLINE
11. 11 Kaplan LM. Leptin, obesity, and liver disease. Gastroenterology 1998 ; 115: 997–1001. MEDLINE
12. 12 Grunfeld C, Zhao C, Fuller J, Pollock A, Moser A, Friedman J, Feingold KR. Endotoxin and cytokines induce expression of leptin, the OB gene product, in hamsters. A role for leptin in the anorexia of infection. J Clin Invest 1996 ; 97: 2152–2157. MEDLINE
13. 13 Kolacynski JW, Nyce MR, Considine RV, Boden G, Nolan JJ, Henry R, Mudallar SR, et al. Acute and chronic effects of insulin on leptin production in humans in vivo and in vitro. Diabetes 1996 ; 45: 699–701. MEDLINE
14. 14 Masuzaki H, Ogawa Y, Hosoda K, Miyawaki T, Hanaoka I, Hiraoka J, Yasuno A, et al. Glucocorticoid regulation of leptin synthesis and secretion in humans: elevated plasma leptin levels in Cushing's syndrome. J Clin Endocrinol Metab 1997 ; 82: 2542–2547. MEDLINE
15. 15 Halleux CM, Servais I, Reul BA, Detry R, Brichard SM. Multihormonal control of ob gene expression and leptin secretion from cultured human visceral adipose tissue: increased responsiveness to glucocorticoids in obesity. J Clin Endocrinol Metab 1998 ; 83: 902–910. MEDLINE
16. 16 Merabet E, Dagogo‐Jack S, Coyne DW, Klein S, Santiago JV, Hmiel SP, Landt M. Increased plasma leptin concentration in end‐stage renal disease. J Clin Endocrinol Metab 1997 ; 82: 847–850. MEDLINE
17. 17 Howard JK, Lord GM, Clutterbuck EJ, Ghatei MA, Pusey CD, Bloom SR. Plasma immunoreactive leptin concentration in end‐stage renal disease. Clin Sci 1997 ; 93: 119–126. MEDLINE
18. 18 Shoji T, Nishizawa Y, Emoto M, Maekawa K, Hiura Y, Tanaka S, Kawagishi T, et al. Renal function and insulin resistance as determinants of plasma leptin levels in patients with NIDDM. Diabetologia 1997 ; 40: 676–679. MEDLINE
19. 19 McCullough AJ, Bugianesi E, Marchesini G, Kalhan SC. Gender‐dependent alterations in serum leptin in alcoholic cirrhosis. Gastroenterology 1998 ; 115: 947–953. MEDLINE
20. 20 Potter JJ, Womack L, Mezey E, Anania FA. Transdifferentiation of rat hepatic stellate cells results in leptin expression. Biochem Biophys Res Commun 1998 ; 244: 178–182. MEDLINE
21. 21 Henriksen JH, Ring‐Larsen H, Kanstrup I‐L, Christensen NJ. Splanchnic and renal elimination and release of catecholamines in cirrhosis. Evidence of enhanced sympathetic nervous activity in patients with decompensated cirrhosis. Gut 1984 ; 25: 1034–1043. MEDLINE
22. 22 Bentsen KD, Henriksen JH, Boesby S, Jensen LT, Hørslev‐Petersen K, Lorenzen I. Hepatic extraction of the aminoterminal propeptide of type III procollagen before and after bile duct ligation in pigs. Liver 1991 ; 11: 310–315. MEDLINE
23. 23 Henriksen JH, Winkler K. Hepatic blood flow determination—a comparison of 99m Tc‐diethyl‐IDA and indocyanine green as hepatic blood flow indicators in man. J Hepatol 1987 ; 4: 66–70. MEDLINE
24. 24 Tygstrup N. Determination of the hepatic galactose elimination capacity after a single intravenous injection in man. Acta Physiol Scand 1963 ; 58: 162–172.
25. 25 Henriksen JH, Bendtsen F, Sørensen TIA, Stadeager C, Ring‐Larsen H. Reduced central blood volume in cirrhosis. Gastroenterology 1989 ; 97: 1506–1513. MEDLINE
26. 26 Møller S, Wiinberg N, Henriksen JH. Non‐invasive 24‐hour ambulatory arterial blood pressure monitoring in cirrhosis. Hepatology 1995 ; 22: 88–95. MEDLINE
27. 27 Albano JDM, Ekins RP, Maritz G, Turner RC. A sensitive precise radioimmunoassay of serum insulin relying on charcoal separation of bound and free hormone moieties. Acta Endocrinol 1972 ; 70: 487–509. MEDLINE
28. 28 Ma Z, Gingerich RL, Santiago JV, Klein S, Smith CH, Landt M. Radioimmunoassay of leptin in human plasma. Clin Chem 1996 ; 42: 942–946. MEDLINE
29. 29 Bado A, Levasseur S, Attoub S, Kermorgant S, Laigneau J‐P, Bortoluzzi M‐N, Moizo L, et al. The stomach is a source of leptin. Nature 1998 ; 394: 790–793. MEDLINE
30. 30 Barrachina MD, Martinez V, Wang L, Wei JT, Taché Y. Synergistic interaction between leptin and cholecystokinin to reduce short‐term food intake in mice. Proc Natl Acad Sci U S A 1997 ; 94: 10455–10460. MEDLINE
31. 31 Sinha MK, Ohannesian JP, Heiman ML, Kriauciunas A, Stephens TW, Magosin S, Marco C, et al. Nocturnal rise of leptin in lean, obese and non‐insulin‐dependent diabetes mellitus subjects. J Clin Invest 1996 ; 97: 1344–1347. MEDLINE
32. 32 Sinha MK. Human leptin: the hormone of adipose tissue. Eur J Endocrinol 1997 ; 136: 461–464. MEDLINE
33. 33 Hanley AJG, Harris SB, Gao XJ, Kwan J, Zinman B. Serum immunoreactive leptin concentrations in a Canadian aboriginal population with high rates of NIDDM. Diabetes Care 1997 ; 20: 1408–1415. MEDLINE
34. 34 Lee GH, Proenca R, Montez JM, Carroll KM, Darvishzadeh JG, Lee JI, Friedman JM. Abnormal splicing of the leptin receptor in diabetic mice. Nature 1996 ; 379: 632–635. MEDLINE
35. 35 Tartaglia LA. The leptin receptor. J Biol Chem 1997 ; 272: 6093–6096. MEDLINE
36. 36 Cumin F, Baum H‐P, Levens N. Leptin is cleared from the circulation primarily by the kidney. Int J Obesity 1996 ; 20: 1120–1126.
37. 37 Cumin F, Baum H‐P, De Gasparo M, Levens N. Removal of endogenous leptin from the circulation by the kidney. Int J Obesity 1997 ; 21: 495–504.
38. 38 Guevara M, Gines P, Jimenez W, Sort P, Fernandez‐Esparrach G, Escorsell A, Bataller R, et al. Increased adrenomedullin levels in cirrhosis: relationship with hemodynamic abnormalities and vasoconstrictor systems. Gastroenterology 1998 ; 114: 336–343. MEDLINE
39. 39 Ring‐Larsen H. Hepatic nephropathy related to haemodynamics. Liver 1983 ; 3: 265–289. MEDLINE
40. 40 Epstein M. Hepatorenal syndrome. In Epstein M (ed): The Kidney in Liver Disease (ed 4). Philadelphia: Hanley & Belfus, Inc.. 1996 ; 75–108.
41. 41 Lonnroth P, Jansson PA, Smith U. Adipose tissue metabolism in humans determined by vein catheterization and microdialysis techniques. Am J Physiol 1994 ; 267: E1035–E1036. MEDLINE
42. 42 Simonsen L, Bülow J, Madsen J. Adipose tissue metabolism in humans determined by vein catheterization and microdialysis techniques. Am J Physiol 1994 ; 266: E357–E365. MEDLINE
43. 43 Friedman JM. Leptin, leptin receptors, and the control of body weight. Nutr Rev 1997 ; 56: S38–S46.
44. 44 Hafner SM, Miettinen H, Karhapaa, Mykkanen A, Laakso M. Leptin concentrations, sex hormones, and cortisol in non‐diabetic men. J Clin Endocrinol Metab 1997 ; 82: 1807–1809. MEDLINE